help button home button Endocrine Society Endocrine Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clevenger, C. V.
Right arrow Articles by Schuler, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clevenger, C. V.
Right arrow Articles by Schuler, L. A.
Endocrine Reviews 24 (1): 1-27
Copyright © 2003 by The Endocrine Society

The Role of Prolactin in Mammary Carcinoma

Charles V. Clevenger, Priscilla A. Furth, Susan E. Hankinson and Linda A. Schuler

Department of Pathology and Laboratory Medicine (C.V.C), University of Pennsylvania, Philadelphia, Pennsylvania 19104; Lombardi Cancer Center (P.A.F.), Department of Oncology, Georgetown University, Washington, D.C. 20057; Channing Laboratories, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, and Department of Epidemiology (S.E.H.), Harvard School of Public Health, Cambridge, Massachusetts 02115; and Department of Comparative Bioscience (L.A.S.), University of Wisconsin, Madison, Wisconsin 53706

Correspondence: Address all correspondence and requests for reprints to: Charles V. Clevenger, M.D., Ph.D., Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104. E-mail: clevengc{at}mail.med.upenn.edu

The contribution of prolactin (PRL) to the pathogenesis and progression of human breast cancer at the cellular, transgenic, and epidemiological levels is increasingly appreciated. Acting at the endocrine and autocrine/paracrine levels, PRL functions to stimulate the growth and motility of human breast cancer cells. The actions of this ligand are mediated by at least six recognized PRL receptor isoforms found on, or secreted by, human breast epithelium. The PRL/PRL receptor complex associates with and activates several signaling networks that are shared with other members of the cytokine receptor superfamily. Coupled with the recently identified intranuclear function of PRL, these networks are integrated into the in vitro and in vivo actions induced by ligand. These findings indicate that antagonists of PRL/PRL receptor interaction or PRL receptor-associated signal transduction may be of considerable utility in the treatment of human breast cancer.




This article has been cited by other articles:


Home page
 J EndocrinolHome page
L. M Arendt, L. C Evans, D. E Rugowski, M. J. Garcia-Barchino, H. Rui, and L. A Schuler
Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processes
J. Endocrinol., October 1, 2009; 203(1): 99 - 110.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
C. Clapp, S. Thebault, M. C. Jeziorski, and G. Martinez De La Escalera
Peptide Hormone Regulation of Angiogenesis
Physiol Rev, October 1, 2009; 89(4): 1177 - 1215.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Walker, O. Fletcher, N. Johnson, B. Coupland, V. A. McCormack, E. Folkerd, L. Gibson, S. G. Hillier, J. M. Holly, S. Moss, et al.
Premenopausal Mammographic Density in Relation to Cyclic Variations in Endogenous Sex Hormone Levels, Prolactin, and Insulin-like Growth Factors
Cancer Res., August 15, 2009; 69(16): 6490 - 6499.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
E. W. LaPensee, S. J. Schwemberger, C. R. LaPensee, E. M. Bahassi, S. E. Afton, and N. Ben-Jonathan
Prolactin confers resistance against cisplatin in breast cancer cells by activating glutathione-S-transferase
Carcinogenesis, August 1, 2009; 30(8): 1298 - 1304.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
E. D. Galsgaard, B. B. Rasmussen, C. G. Folkesson, L. M. Rasmussen, M. W. Berchtold, L. Christensen, and S. Panina
Re-evaluation of the prolactin receptor expression in human breast cancer
J. Endocrinol., April 1, 2009; 201(1): 115 - 128.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Plotnikov, B. Varghese, T. H. Tran, C. Liu, H. Rui, and S. Y. Fuchs
Impaired Turnover of Prolactin Receptor Contributes to Transformation of Human Breast Cells
Cancer Res., April 1, 2009; 69(7): 3165 - 3172.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
L. M. Arendt, T. L. Grafwallner-Huseth, and L. A. Schuler
Prolactin-Growth Factor Crosstalk Reduces Mammary Estrogen Responsiveness Despite Elevated ER{alpha} Expression
Am. J. Pathol., March 1, 2009; 174(3): 1065 - 1074.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
D. L. Kleinberg, T. L. Wood, P. A. Furth, and A. V. Lee
Growth Hormone and Insulin-Like Growth Factor-I in the Transition from Normal Mammary Development to Preneoplastic Mammary Lesions
Endocr. Rev., February 1, 2009; 30(1): 51 - 74.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
T. M. Piazza, J.-C. Lu, K. C. Carver, and L. A. Schuler
Src Family Kinases Accelerate Prolactin Receptor Internalization, Modulating Trafficking and Signaling in Breast Cancer Cells
Mol. Endocrinol., February 1, 2009; 23(2): 202 - 212.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
F. Fang, A. J. Flegler, P. Du, S. Lin, and C. V. Clevenger
Expression of Cyclophilin B is Associated with Malignant Progression and Regulation of Genes Implicated in the Pathogenesis of Breast Cancer
Am. J. Pathol., January 1, 2009; 174(1): 297 - 308.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Zheng, J. E. Koblinski, L. V. Dutson, Y. B. Feeney, and C. V. Clevenger
Prolyl Isomerase Cyclophilin A Regulation of Janus-Activated Kinase 2 and the Progression of Human Breast Cancer
Cancer Res., October 1, 2008; 68(19): 7769 - 7778.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. R. Hugo, D. C. Borcherding, K. S. Gersin, J. Loftus, and N. Ben-Jonathan
Prolactin Release by Adipose Explants, Primary Adipocytes, and LS14 Adipocytes
J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 4006 - 4012.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
R. S. Muraoka-Cook, M. Sandahl, D. Hunter, L. Miraglia, and H. S. Earp III
Prolactin and ErbB4/HER4 Signaling Interact via Janus Kinase 2 to Induce Mammary Epithelial Cell Gene Expression Differentiation
Mol. Endocrinol., October 1, 2008; 22(10): 2307 - 2321.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. A. Abdelmagid and C. K. L. Too
Prolactin and Estrogen Up-Regulate Carboxypeptidase-D to Promote Nitric Oxide Production and Survival of MCF-7 Breast Cancer Cells
Endocrinology, October 1, 2008; 149(10): 4821 - 4828.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
B. Varghese, H. Barriere, C. J. Carbone, A. Banerjee, G. Swaminathan, A. Plotnikov, P. Xu, J. Peng, V. Goffin, G. L. Lukacs, et al.
Polyubiquitination of Prolactin Receptor Stimulates Its Internalization, Postinternalization Sorting, and Degradation via the Lysosomal Pathway
Mol. Cell. Biol., September 1, 2008; 28(17): 5275 - 5287.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
C. S. Watson, Y.-J. Jeng, and M. Y. Kochukov
Nongenomic actions of estradiol compared with estrone and estriol in pituitary tumor cell signaling and proliferation
FASEB J, September 1, 2008; 22(9): 3328 - 3336.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
K. C. Carver and L. A. Schuler
Prolactin Does Not Require Insulin-Like Growth Factor Intermediates but Synergizes with Insulin-Like Growth Factor I in Human Breast Cancer Cells
Mol. Cancer Res., April 1, 2008; 6(4): 634 - 643.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Plotnikov, Y. Li, T. H. Tran, W. Tang, J. P. Palazzo, H. Rui, and S. Y. Fuchs
Oncogene-Mediated Inhibition of Glycogen Synthase Kinase 3{beta} Impairs Degradation of Prolactin Receptor
Cancer Res., March 1, 2008; 68(5): 1354 - 1361.
[Abstract] [Full Text] [PDF]

Home page
 J PsychopharmacolHome page
P. W. Harvey, D. J. Everett, and C. J. Springall
Adverse effects of prolactin in rodents and humans: breast and prostate cancer
J Psychopharmacol, March 1, 2008; 22(2_suppl): 20 - 27.
[Abstract] [PDF]

Home page
 J EndocrinolHome page
G. Swaminathan, B. Varghese, C. Thangavel, C. J Carbone, A. Plotnikov, K G S. Kumar, E. M Jablonski, C. V Clevenger, V. Goffin, L. Deng, et al.
Prolactin stimulates ubiquitination, initial internalization, and degradation of its receptor via catalytic activation of Janus kinase 2
J. Endocrinol., February 1, 2008; 196(2): R1 - R7.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
N. Ben-Jonathan, C. R. LaPensee, and E. W. LaPensee
What Can We Learn from Rodents about Prolactin in Humans?
Endocr. Rev., February 1, 2008; 29(1): 1 - 41.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
X. Ren, X. Zhang, A. S. Kim, A. M. Mikheev, M. Fang, R. C. Sullivan, R. E. Bumgarner, and H. Zarbl
Comparative genomics of susceptibility to mammary carcinogenesis among inbred rat strains: role of reduced prolactin signaling in resistance of the Copenhagen strain
Carcinogenesis, January 1, 2008; 29(1): 177 - 185.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J.-B. Jomain, E. Tallet, I. Broutin, S. Hoos, J. van Agthoven, A. Ducruix, P. A. Kelly, B. B. Kragelund, P. England, and V. Goffin
Structural and Thermodynamic Bases for the Design of Pure Prolactin Receptor Antagonists: X-RAY STRUCTURE OF Del1-9-G129R-hPRL
J. Biol. Chem., November 9, 2007; 282(45): 33118 - 33131.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. J. Waters and J. L. Barclay
Does Growth Hormone Drive Breast and Other Cancers?
Endocrinology, October 1, 2007; 148(10): 4533 - 4535.
[Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
L. M. Neilson, J. Zhu, J. Xie, M. G. Malabarba, K. Sakamoto, K.-U. Wagner, R. A. Kirken, and H. Rui
Coactivation of Janus Tyrosine Kinase (Jak)1 Positively Modulates Prolactin-Jak2 Signaling in Breast Cancer: Recruitment of ERK and Signal Transducer and Activator of Transcription (Stat)3 and Enhancement of Akt and Stat5a/b Pathways
Mol. Endocrinol., September 1, 2007; 21(9): 2218 - 2232.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
K. Sakamoto, B. A. Creamer, A. A. Triplett, and K.-U. Wagner
The Janus Kinase 2 Is Required for Expression and Nuclear Accumulation of Cyclin D1 in Proliferating Mammary Epithelial Cells
Mol. Endocrinol., August 1, 2007; 21(8): 1877 - 1892.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
S. Seoane, I. Ben, V. Centeno, and R. Perez-Fernandez
Cellular Expression Levels of the Vitamin D Receptor Are Critical to Its Transcriptional Regulation by the Pituitary Transcription Factor Pit-1
Mol. Endocrinol., July 1, 2007; 21(7): 1513 - 1525.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
A. Vaclavicek, J. L. Bermejo, R. K Schmutzler, C. Sutter, B. Wappenschmidt, A. Meindl, M. Kiechle, N. Arnold, B. H F Weber, D. Niederacher, et al.
Polymorphisms in the Janus kinase 2 (JAK)/signal transducer and activator of transcription (STAT) genes: putative association of the STAT gene region with familial breast cancer
Endocr. Relat. Cancer, June 1, 2007; 14(2): 267 - 277.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. S. Tworoger, B. Sorensen, J. Chubak, M. Irwin, F. Z. Stanczyk, C. M. Ulrich, J. Potter, and A. McTiernan
Effect of a 12-Month Randomized Clinical Trial of Exercise on Serum Prolactin Concentrations in Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 895 - 899.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
O. Eyal, J.-B. Jomain, C. Kessler, V. Goffin, and S. Handwerger
Autocrine Prolactin Inhibits Human Uterine Decidualization: A Novel Role for Prolactin
Biol Reprod, May 1, 2007; 76(5): 777 - 783.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. S. Tworoger, A. H. Eliassen, P. Sluss, and S. E. Hankinson
A Prospective Study of Plasma Prolactin Concentrations and Risk of Premenopausal and Postmenopausal Breast Cancer
J. Clin. Oncol., April 20, 2007; 25(12): 1482 - 1488.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
A J Craven, A J Nixon, M G Ashby, C J Ormandy, K Blazek, R J Wilkins, and A J Pearson
Prolactin delays hair regrowth in mice.
J. Endocrinol., November 1, 2006; 191(2): 415 - 425.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
A. Diogenes, A. M. Patwardhan, N. A. Jeske, N. B. Ruparel, V. Goffin, A. N. Akopian, and K. M. Hargreaves
Prolactin Modulates TRPV1 in Female Rat Trigeminal Sensory Neurons
J. Neurosci., August 2, 2006; 26(31): 8126 - 8136.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
C. Manhes, C. Kayser, P. Bertheau, B. Kelder, J. J Kopchick, P. A Kelly, P. Touraine, and V. Goffin
Local over-expression of prolactin in differentiating mouse mammary gland induces functional defects and benign lesions, but no carcinoma.
J. Endocrinol., August 1, 2006; 190(2): 271 - 285.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
J. D Bishop, W. L. Nien, S. M Dauphinee, and C. K L Too
Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells.
J. Endocrinol., August 1, 2006; 190(2): 307 - 312.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
M. P. Gillam, M. E. Molitch, G. Lombardi, and A. Colao
Advances in the Treatment of Prolactinomas
Endocr. Rev., August 1, 2006; 27(5): 485 - 534.
[Abstract] [Full Text] [PDF]

Home page
 Hum Exp ToxicolHome page
P W Harvey, D J Everett, and C J Springall
Hyperprolactinaemia as an adverse effect in regulatory and clinical toxicology: role in breast and prostate cancer
Human and Experimental Toxicology, July 1, 2006; 25(7): 395 - 404.
[Abstract] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. M. Faupel-Badger, S. A. Prindiville, D. Venzon, B. K. Vonderhaar, J. A. Zujewski, and J. Eng-Wong
Effects of raloxifene on circulating prolactin and estradiol levels in premenopausal women at high risk for developing breast cancer.
Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1153 - 1158.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. S. Bridges and E. M. Byrnes
Reproductive Experience Reduces Circulating 17{beta}-Estradiol and Prolactin Levels during Proestrus and Alters Estrogen Sensitivity in Female Rats
Endocrinology, May 1, 2006; 147(5): 2575 - 2582.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
S. Seoane and R. Perez-Fernandez
The Vitamin D Receptor Represses Transcription of the Pituitary Transcription Factor Pit-1 Gene without Involvement of the Retinoid X Receptor
Mol. Endocrinol., April 1, 2006; 20(4): 735 - 748.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Vaclavicek, K. Hemminki, C. R. Bartram, K. Wagner, B. Wappenschmidt, A. Meindl, R. K. Schmutzler, R. Klaes, M. Untch, B. Burwinkel, et al.
Association of Prolactin and Its Receptor Gene Regions with Familial Breast Cancer
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1513 - 1519.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
L. M. Arendt, T. A. Rose-Hellekant, E. P. Sandgren, and L. A. Schuler
Prolactin Potentiates Transforming Growth Factor {alpha} Induction of Mammary Neoplasia in Transgenic Mice
Am. J. Pathol., April 1, 2006; 168(4): 1365 - 1374.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
F E Utama, M J LeBaron, L M Neilson, A S Sultan, A F Parlow, K-U Wagner, and H Rui
Human prolactin receptors are insensitive to mouse prolactin: implications for xenotransplant modeling of human breast cancer in mice.
J. Endocrinol., March 1, 2006; 188(3): 589 - 601.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Glezer, C. R. J. Soares, J. G. Vieira, D. Giannella-Neto, M. T. C. P. Ribela, V. Goffin, and M. D. Bronstein
Human Macroprolactin Displays Low Biological Activity via Its Homologous Receptor in a New Sensitive Bioassay
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1048 - 1055.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. S. Tworoger, P. Sluss, and S. E. Hankinson
Association between Plasma Prolactin Concentrations and Risk of Breast Cancer among Predominately Premenopausal Women
Cancer Res., February 15, 2006; 66(4): 2476 - 2482.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Z. Nouhi, N. Chughtai, S. Hartley, E. Cocolakis, J.-J. Lebrun, and S. Ali
Defining the Role of Prolactin as an Invasion Suppressor Hormone in Breast Cancer Cells
Cancer Res., February 1, 2006; 66(3): 1824 - 1832.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
G. Albrektsen, I. Heuch, S. Thoresen, and G. Kvale
Clinical Stage of Breast Cancer by Parity, Age at Birth, and Time Since Birth: A Progressive Effect of Pregnancy Hormones?
Cancer Epidemiol. Biomarkers Prev., January 1, 2006; 15(1): 65 - 69.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J.-C. Lu, T. M. Piazza, and L. A. Schuler
Proteasomes Mediate Prolactin-induced Receptor Down-regulation and Fragment Generation in Breast Cancer Cells
J. Biol. Chem., October 7, 2005; 280(40): 33909 - 33916.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. P. Pinheiro, M. D. Holmes, M. N. Pollak, R. L. Barbieri, and S. E. Hankinson
Racial Differences in Premenopausal Endogenous Hormones
Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2147 - 2153.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
S. B Rulli and I. Huhtaniemi
What have gonadotrophin overexpressing transgenic mice taught us about gonadal function?
Reproduction, September 1, 2005; 130(3): 283 - 291.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
C Gil-Puig, S Seoane, M Blanco, M Macia, T Garcia-Caballero, C Segura, and R Perez-Fernandez
Pit-1 is expressed in normal and tumorous human breast and regulates GH secretion and cell proliferation
Eur. J. Endocrinol., August 1, 2005; 153(2): 335 - 344.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. H. Gutzman, S. E. Nikolai, D. E. Rugowski, J. J. Watters, and L. A. Schuler
Prolactin and Estrogen Enhance the Activity of Activating Protein 1 in Breast Cancer Cells: Role of Extracellularly Regulated Kinase 1/2-Mediated Signals to c-fos
Mol. Endocrinol., July 1, 2005; 19(7): 1765 - 1778.
[Abstract] [Full Text] [PDF]

Home page
 Occup. Environ. Med.Home page
N Hakansson, C Stenlund, P Gustavsson, C Johansen, and B Floderus
Arc and resistance welding and tumours of the endocrine glands: a Swedish case-control study with focus on extremely low frequency magnetic fields
Occup. Environ. Med., May 1, 2005; 62(5): 304 - 308.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
V. Goffin, S. Bernichtein, P. Touraine, and P. A. Kelly
Development and Potential Clinical Uses of Human Prolactin Receptor Antagonists
Endocr. Rev., May 1, 2005; 26(3): 400 - 422.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
S. L. Miller, J. E. DeMaria, D. O. Freier, A. M. Riegel, and C. V. Clevenger
Novel Association of Vav2 and Nek3 Modulates Signaling through the Human Prolactin Receptor
Mol. Endocrinol., April 1, 2005; 19(4): 939 - 949.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
M. T. Tilli, R. Reiter, A. S. Oh, R. T. Henke, K. McDonnell, G. I. Gallicano, P. A. Furth, and A. T. Riegel
Overexpression of an N-Terminally Truncated Isoform of the Nuclear Receptor Coactivator Amplified in Breast Cancer 1 Leads to Altered Proliferation of Mammary Epithelial Cells in Transgenic Mice
Mol. Endocrinol., March 1, 2005; 19(3): 644 - 656.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. H. Gutzman, D. E. Rugowski, M. D. Schroeder, J. J. Watters, and L. A. Schuler
Multiple Kinase Cascades Mediate Prolactin Signals to Activating Protein-1 in Breast Cancer Cells
Mol. Endocrinol., December 1, 2004; 18(12): 3064 - 3075.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
A. Hewetson, S. L. Moore, and B. S. Chilton
Prolactin Signals Through RUSH/SMARCA3 in the Absence of a Physical Association with Stat5a
Biol Reprod, December 1, 2004; 71(6): 1907 - 1912.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
D. Piwnica, P. Touraine, I. Struman, S. Tabruyn, G. Bolbach, C. Clapp, J. A. Martial, P. A. Kelly, and V. Goffin
Cathepsin D Processes Human Prolactin into Multiple 16K-Like N-Terminal Fragments: Study of Their Antiangiogenic Properties and Physiological Relevance
Mol. Endocrinol., October 1, 2004; 18(10): 2522 - 2542.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. S. Tworoger, A. H. Eliassen, B. Rosner, P. Sluss, and S. E. Hankinson
Plasma Prolactin Concentrations and Risk of Postmenopausal Breast Cancer
Cancer Res., September 15, 2004; 64(18): 6814 - 6819.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
Y. Li, K. G. Suresh Kumar, W. Tang, V. S. Spiegelman, and S. Y. Fuchs
Negative Regulation of Prolactin Receptor Stability and Signaling Mediated by SCF{beta}-TrCP E3 Ubiquitin Ligase
Mol. Cell. Biol., May 1, 2004; 24(9): 4038 - 4048.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. M. Karp, H. Pan, M. Zhang, D. J. Buckley, L. A. Schuler, and A. R. Buckley
Identification of HRPAP20: A Novel Phosphoprotein that Enhances Growth and Survival in Hormone-Responsive Tumor Cells
Cancer Res., February 1, 2004; 64(3): 1016 - 1025.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
O. Serri and S. Ezzat
More about hyperprolactinemia
Can. Med. Assoc. J., January 20, 2004; 170(2): 177 - 177.
[Full Text]

Home page
 CMAJHome page
C. S. Kovacs
More about hyperprolactinemia
Can. Med. Assoc. J., January 20, 2004; 170(2): 176 - 177.
[Full Text]

Home page
 Biol. Reprod.Home page
R. M. Bigsby, A. Caperell-Grant, N. Berry, K. Nephew, and D. Lubahn
Estrogen Induces a Systemic Growth Factor Through an Estrogen Receptor-Alpha-Dependent Mechanism
Biol Reprod, January 1, 2004; 70(1): 178 - 183.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. D. Schroeder, J. L. Brockman, A. M. Walker, and L. A. Schuler
Inhibition of Prolactin (PRL)-Induced Proliferative Signals in Breast Cancer Cells by a Molecular Mimic of Phosphorylated PRL, S179D-PRL
Endocrinology, December 1, 2003; 144(12): 5300 - 5307.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Bernichtein, C. Kayser, K. Dillner, S. Moulin, J. J. Kopchick, J. A. Martial, G. Norstedt, O. Isaksson, P. A. Kelly, and V. Goffin
Development of Pure Prolactin Receptor Antagonists
J. Biol. Chem., September 19, 2003; 278(38): 35988 - 35999.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. A. Olayioye, M. A. Guthridge, F. C. Stomski, A. F. Lopez, J. E. Visvader, and G. J. Lindeman
Threonine 391 Phosphorylation of the Human Prolactin Receptor Mediates a Novel Interaction with 14-3-3 Proteins
J. Biol. Chem., August 29, 2003; 278(35): 32929 - 32935.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society